PART I Overview We are a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. Our products and technology, which include our HiFi long-read sequencing technology, address a broad set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiol...
Q2 FY2026 — expected 2026-08-06
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001299130-26-000034 | EDGAR | 83K words |
| 2025-03-17 | 2024-12-31 | 0001299130-25-000061 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001299130-24-000054 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0001299130-23-000032 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001299130-22-000030 | EDGAR | — |
| 2021-02-26 | 2020-12-31 | 0001299130-21-000098 | EDGAR | — |
| 2020-02-28 | 2019-12-31 | 0001299130-20-000008 | EDGAR | — |
| 2019-02-26 | 2018-12-31 | 0001299130-19-000014 | EDGAR | — |
| 2018-02-26 | 2017-12-31 | 0001299130-18-000018 | EDGAR | — |
| 2017-03-06 | 2016-12-31 | 0001299130-17-000016 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001299130-25-000168 | EDGAR | 54K words |
| 2025-08-07 | 2025-06-30 | 0001299130-25-000156 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001299130-25-000102 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001299130-24-000183 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001299130-24-000169 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001299130-24-000111 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001299130-23-000139 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0001299130-23-000098 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001299130-23-000048 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001299130-22-000136 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001299130-22-000101 | EDGAR | — |
| 2022-05-06 | 2022-03-31 | 0001299130-22-000053 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-06 | 0001299130-26-000053 | EDGAR | 1K words |
| 2026-03-05 | 0001299130-26-000046 | EDGAR | — |
| 2026-02-12 | 0001299130-26-000017 | EDGAR | — |
| 2026-02-03 | 0001299130-26-000012 | EDGAR | — |
| 2026-02-02 | 0001104659-26-009014 | EDGAR | — |
| 2026-01-12 | 0001299130-26-000005 | EDGAR | — |
| 2025-11-05 | 0001299130-25-000165 | EDGAR | — |
| 2025-08-07 | 0001299130-25-000152 | EDGAR | — |
| 2025-06-06 | 0001299130-25-000140 | EDGAR | — |
| 2025-05-08 | 0001299130-25-000099 | EDGAR | — |
306 total filings indexed. 274 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001299130 |
| Ticker | PACB |
| Exchange | Nasdaq |
| SIC | 3826: Laboratory Analytical Instruments |
| Incorporated | DE |
| Website | https://www.pacb.com |
| Listed | 2010-10-27 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report